Entry stagen/a
Check size$1M to $30M
Leads roundsYes
FocusLife sciences, Healthtech
Latest fundn/a
Investing team4 peopleNo activity since Sep
Who you would pitch at Avant Bio
4 people on the investing team, 3 of them partners who can make the call. Partners are listed first.
Daniella KranjacFounding General PartnerHer role is defined solely by this contact information in the provided text.
Ole Henrik Bang-AndreasenPartnerHe has spent ten years investing in life science companies across public and private markets.
Sebastien LatapiePartnerHe leads growth investments and serves on the board of PathPresenter.
Peter LeeInvestorHis recent investments include a Series A in a consumer company.
Work here and something is wrong? Ask for a correction.
Writes $1M to $30M checks. Its smallest check is larger than 83% of firms in the atlas.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Notable investments
Nomic BioPathPresenterAbbeLightIntrepid LabsPL BioScience
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when Avant Bio is active
One email when this firm shows new activity. Nothing else.
Questions
What stage does Avant Bio invest in?
Avant Bio has not reported an entry stage.
How much does Avant Bio invest?
Avant Bio reports checks of $1M to $30M.
Does Avant Bio lead rounds?
Yes. Avant Bio says it can lead.
Who are the partners at Avant Bio?
Daniella Kranjac (Founding General Partner), Ole Henrik Bang-Andreasen (Partner), Sebastien Latapie (Partner).
Is Avant Bio active right now?
No recent activity since September 2026.
Work at Avant Bio? Claim or correct this profile.